Categories: News

NYSE Content Advisory: Pre-Market Update + BETA Technologies Raises Over $1 Billion in IPO

NEW YORK, Nov. 4, 2025 /PRNewswire/ — The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today’s NYSE Pre-market update for market insights before trading begins. 

- Advertisement -

Kristen Scholer delivers the pre-market update on November 4th

- Advertisement -
  • Equities are pulling back early Tuesday after a run fueled by AI stocks. The S&P 500 added 0.2% Monday on the back of a 4% rally in shares of Amazon. The company inked a deal with OpenAI that sent it to a record close.
  • At a Summit in Hong Kong, Morgan Stanley’s Ted Pick and Goldman Sachs’ David Solomon warned of a double-digit pop after the S&P 500 surged more than 35% from its April lows.
  • Beta Technologies is set to debut on the NYSE today after pricing an upsized IPO at $34 each. The electric aircraft developed raised more than $1 billion by offering nearly 30 million shares. It will trade under the ticker symbol BETA.


Opening Bell


Beta Technologies (NYSE: BETA) celebrates its initial public offering

- Advertisement -


Closing Bell


Capital Group celebrates the 3-year anniversary of the launch of CGMS, CGMU and CGSD and the listing of its three newest ETFs – CGGG, CGVV and CGHY.

- Advertisement -


Click here to download the NYSE TV App

- Advertisement -

Video – https://mma.prnewswire.com/media/2813192/NYSE_Market_Update_November_4.mp4 
Logo – https://mma.prnewswire.com/media/2581322/5600792/New_York_Stock_Exchange_Logo.jpg

- Advertisement -

 

- Advertisement -

View original content:https://www.prnewswire.co.uk/news-releases/nyse-content-advisory-pre-market-update–beta-technologies-raises-over-1-billion-in-ipo-302604121.html

- Advertisement -

Recent Posts

Ocular Therapeutix Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

February 06, 2026 16:01 ET  | Source: Ocular Therapeutix, Inc. BEDFORD, Mass., Feb. 06, 2026…

2 hours ago

NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

February 06, 2026 16:01 ET  | Source: NewAmsterdam Pharma N.V. NAARDEN, The Netherlands and MIAMI,…

2 hours ago

Novartis breaks ground on new global Biomedical Research center in San Diego to accelerate drug discovery

New facility will enable end‑to‑end discovery across key disease areas and technology platforms, joining existing…

2 hours ago

The Ministry of Finance and the International Monetary Fund to launch tomorrow the second edition of the AlUla Conference for Emerging Market Economies

AlUla, Saudi Arabia, Feb. 7, 2026 /PRNewswire/ -- The second edition of the AlUla Conference…

2 hours ago

Roches fenebrutinib is the first investigational medicine in over a decade that reduces disability progression in primary progressive multiple sclerosis (PPMS)

Late-breaking Phase III FENtrepid results presented at ACTRIMS show investigational fenebrutinib met its primary endpoint…

2 hours ago

Lexicon Announces Closing of Approximately $94.6 Million Public Offering and Concurrent Private Placement

February 06, 2026 17:17 ET  | Source: Lexicon Pharmaceuticals, Inc. THE WOODLANDS, Texas, Feb. 06,…

2 hours ago